Skip to content
10-Q

Quarterly Report

AMICUS THERAPEUTICS, INC.

0001178879-25-000015

← back to feed
Filed
Nov 4, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 24, 2025 308.53M sh
Shares Diluted Q3 2025 · Sep 30, 2025 310.43M sh
Shares Diluted Q3 2025 · Sep 30, 2025 308.14M sh
Shares Diluted Q3 2025 · Sep 30, 2024 304.69M sh
Shares Diluted Q3 2025 · Sep 30, 2024 303.79M sh
Capex Q3 2025 · Sep 30, 2025 $3M
Capex Q3 2025 · Sep 30, 2024 $3.27M
Operating Cash Flow Q3 2025 · Sep 30, 2025 $16.89M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$29.98M
Long Term Debt Q3 2025 · Sep 30, 2025 $391.99M
Long Term Debt Q3 2025 · Dec 31, 2024 $390.11M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $190.55M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $213.75M
Cash And Equivalents Q3 2025 · Sep 30, 2024 $233.65M
Stockholders Equity Q3 2025 · Sep 30, 2025 $230.42M
Stockholders Equity Q3 2025 · Jun 30, 2025 $204.3M
Stockholders Equity Q3 2025 · Dec 31, 2024 $194.05M
Stockholders Equity Q3 2025 · Sep 30, 2024 $178.83M
Stockholders Equity Q3 2025 · Jun 30, 2024 $132.52M
Stockholders Equity Q3 2025 · Dec 31, 2023 $160.17M
Current Liabilities Q3 2025 · Sep 30, 2025 $198.93M
Current Liabilities Q3 2025 · Dec 31, 2024 $148.7M
Total Liabilities Q3 2025 · Sep 30, 2025 $638.39M
Total Liabilities Q3 2025 · Dec 31, 2024 $590.99M
Current Assets Q3 2025 · Sep 30, 2025 $594.07M
Current Assets Q3 2025 · Dec 31, 2024 $504.74M
Total Assets Q3 2025 · Sep 30, 2025 $868.81M
Total Assets Q3 2025 · Dec 31, 2024 $785.03M
Eps Diluted Q3 2025 · Sep 30, 2025 $0.06
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.09
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.02
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.23
Eps Basic Q3 2025 · Sep 30, 2025 $0.06
Eps Basic Q3 2025 · Sep 30, 2025 −$0.09
Eps Basic Q3 2025 · Sep 30, 2024 −$0.02
Eps Basic Q3 2025 · Sep 30, 2024 −$0.23
Sga Expense Q3 2025 · Sep 30, 2025 $90.04M
Sga Expense Q3 2025 · Sep 30, 2025 $266.41M
Sga Expense Q3 2025 · Sep 30, 2024 $75.11M
Sga Expense Q3 2025 · Sep 30, 2024 $236.71M
Net Income Q3 2025 · Sep 30, 2025 $17.31M
Net Income Q3 2025 · Sep 30, 2025 −$28.8M
Net Income Q3 2025 · Sep 30, 2024 −$6.73M
Net Income Q3 2025 · Sep 30, 2024 −$70.85M
Operating Income Q3 2025 · Sep 30, 2025 $34.27M
Operating Income Q3 2025 · Sep 30, 2025 $16.84M
Operating Income Q3 2025 · Sep 30, 2024 $21.66M
Operating Income Q3 2025 · Sep 30, 2024 $8.91M
Gross Profit Q3 2025 · Sep 30, 2025 $149.59M
Gross Profit Q3 2025 · Sep 30, 2025 $402.62M
Gross Profit Q3 2025 · Sep 30, 2024 $128.24M
Gross Profit Q3 2025 · Sep 30, 2024 $340.48M
Revenue Q3 2025 · Sep 30, 2025 $169.06M
Revenue Q3 2025 · Sep 30, 2025 $449M
Revenue Q3 2025 · Sep 30, 2024 $141.52M
Revenue Q3 2025 · Sep 30, 2024 $378.59M